Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-25 @ 3:53 AM
NCT ID:
NCT03935802
Eligibility Criteria:
Inclusion Criteria:
* histologically confirmed invasive breast carcinoma
* age \>= 18 years
* exclusive treatment at the Jena University Hospital
* complete curative-intended adjuvant or definite radiotherapy
* at least 2 blood collections (before the start of therapy, after the end of the RT)
Exclusion Criteria:
* presence of metastases
* recurrence
* DCIS, inflammatory breast cancer
* second malignancy \<10 years before diagnosis of breast cancer
* radiotherapeutic pretreatment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT03935802
Study Brief:
Protocol Section:
NCT03935802